Experts say herd immunity is said to have been developed in a population segment if at least 50-60 per cent of those are found to have the presence of antibodies in a sero-prevalence survey.
If people are careful and India is able to vaccinate a large number of population, then the third wave of COVID-19 pandemic may not even come, said All India Institute of Medical Sciences Director Dr Randeep Guleria on Thursday.
T D Dogra, who heads Forensic Medicines and Toxicology Department and is next to Venugopal in seniority, was appointed AIIMS' acting chief.
The Supreme Court has dismissed the Centre's petition seeking review of its order quashing the health ministry's move to fix 65 years as the upper age limit for the All India Institute of Medical Sciences director -- which led to the premature retirement of P Venugopal last year.
The Delhi high court on Wednesday refused to extend the term of All India Institute of Medical Sciences Director P Venugopal and dismissed the plea of a patient's mother seeking his extension by six months to help her son receive final treatment under him. The court also pulled up the petitioner, whose nine-year-old son's heart ailment is allegedly being treated by Venugopal, for filling such petition. The AIIMS director is retiring today.
Justice Gita Mittal asked AIIMS director P Venugopal and Union Health Minister Anbumani Ramadoss to file their replies by October 31 on the contempt petition of one Dr Manoj Kumar.
In a setback to AIIMS Director P Venugopal, the Delhi high court on Thursday gave a green signal to the premier institute's governing body to decide on his continuance in the top slot while holding that he could not occupy the additional post of a pr
"Dr Manmohan Singh, soon after becoming the prime minister, had himself carried a small table for us to have tea comfortably at his Safdarjung Lane residence instead of asking his house help," Dr Srinath Reddy, who was the chairperson of the PM's medical panel, recalled.
Dr Guleria was appointed as the director for a term of five years on March 28, 2017.
A bench of Justices B R Gavai and Sandeep Mehta asked the AIIMS director to constitute the board and submit a report to it in two weeks.
Kejriwal had alleged he was not being administered insulin in jail leading to "alarming" rise in his blood sugar levels.
The 66-year-old, who had been appointed to the post on July three, 2003, for a five-year-term came to his office in the AIIMS barely hours after the Supreme Court verdict came out and reassumed charge. Venugopal was accompanied by resident doctors and faculty members who have supported him all along in his tussle with Union Health Minister Anbumani Ramadoss.
The SLP filed by AIIMS assailed the judgement on the ground that the High Court had committed a grave error by declaring that there was no upper age limit for the director.
A bench of Justices Tarun Chatterjee and H S Bedi upheld the appeal filed by Venugopal challenging the impugned law as being discriminatory and malafidely brought to superannuate him. Venugopal had contended that the amendment was brought with the sole purpose of removing him from his office due to his differences with Ramadoss.
A fresh attempt by Health Minister Anbumani Ramadoss to ease out All India Institute of Medical Sciences Director P Venugopal from his post failed again on Friday when the Union Cabinet did not take up an ordinance to fix the term of the head of the premier medical institute. Reports said Ramadoss, who is at loggerheads with Venugopal, had planned to get the ordinance cleared by the Cabinet but it was not taken up. An attempt by him before the monsoon session had also failed.
Earlier in August, the Centre was directed by the Delhi High Court to file a reply on a public interest litigation challenging Venugopal's appointment as Director.
The tenure of the incumbent AIIMS director, Dr Randeep Guleria, which was set to end on March 24, was extended by three months.
The copies of the new charges will be circulated not only to Venugopal but also to all governing body members of the premier institute and its faculty.
With a view to streamline treatment facilities for MPs, All India Institute of Medical Sciences (AIIMS) Delhi has come up with a set of standard operating procedures (SOPs) that include providing a nodal officer to coordinate and facilitate medical care arrangements.
She claimed that officials haven't given her any deadline when she will get the body.
As India witnessed the highest number of Covid cases in over four months, former All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria on Wednesday said the new XBB.1.16 variant could be driving the recent rise but emphasised there was no need for panic as long it does not cause severe illness and deaths.
At AIIMS, 23 patients are being treated for this fungal infection. Out of them, 20 are still Covid-19 positive and the rest are negative for Covid. Many states have reported more than 500 cases of mucormycosis, said Guleria.
According to some experts, there is not much difference in the number of seasonal flu cases and that of COVID-19, even though they stressed that surveillance for newer variants should continue in the off chance of a new lineage of coronavirus catching the country off guard.
"None of those infected is serious. We are taking all precautions related to Covid-19," Director General (Delhi Prisons) Sandeep Goel said.
The current Covid situation in India is under control and there are no reasons to panic, said Dr N K Arora, the chairperson of National Technical Advisory Group on Immunization (NTAGI).
As around 5,000 nurses went on strike from the afternoon hampering patient care services at the premier hospital, AIIMS Director Randeep Guleria in a video message termed the strike in the time of pandemic as "inappropriate and unfortunate".
Union Health Minister Mansukh Mandaviya on Tuesday told Bharatiya Janata Party MPs that Covid vaccination for children is likely to start soon, sources said.
Kids mostly have mild illnesses and recover with just symptomatic treatment.
It asked the board to determine whether the pregnancy if terminated could risk the life of the woman or not.
The decision to remove it from the guidelines comes in the backdrop of some clinicians and scientists writing to Principal Scientific Advisor K Vijay Raghavan cautioning against the "irrational and non-scientific use" of convalescent plasma for COVID-19 in the country.
Until a sizeable number of the population are vaccinated, Covid-appropriate behaviour needs to be followed aggressively, he said and stressed on the need for stricter surveillance and area-specific lockdowns in case of a significant surge.
The trial is being conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12 to 18 years followed by the age group of 6 to 12. Trials for children between the ages of and 2-6 years are currently undergoing trials.
The Indian Olympic Association secretary general Rajeev Mehta on Monday requested the Union Health Minister Harsh Vardhan to expedite the process for the vaccination of the country's Tokyo Olympic-bound athletes and officials against COVID-19.
Healthcare workers at the frontline of India's COVID-19 battle got their first jabs after Prime Minister Narendra Modi launched the world's biggest drive via video conferencing.
As of Friday, Gujarat's COVID-19 count stood at 7,403 cases, of which 5,260 were from Ahmedabad district alone, while of the 449 deaths in the state, 343 were from the city.
"One CT scan is equivalent to 300 to 400 chest x-rays. According to data, repeated CT scans in younger age groups increase the risk of cancer in later life. Exposing yourself to radiation again and again may cause damage. So, there is no point in doing CT scan in mild COVID-19 if the oxygen saturation is normal," Guleria said.
According to the AIIMS director, there are 10-15 per cent of people who may witness severe infection and may need extra medicines like Remdesivir, oxygen or plasma. Less than five per cent of patients need to be operated on a ventilator, he informed.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances